Cargando…

SUN-078 Clinical, Hormonal, Psychosexual Aspects, Gonadal Tumors and Genetic Background of an Androgen Insensitivity Syndrome Cohort

Introduction: Androgen Insensitivity Syndrome (AIS) is the most common cause of Differences of Sexual Development (DSD) in 46, XY individuals. It is a X-linked genetic disease caused by allelic variants in the Androgen Receptor Gene (Xq11-12), leading to 3 different phenotypes: Complete (CAIS), Part...

Descripción completa

Detalles Bibliográficos
Autores principales: Batista, Rafael Loch, Ramos, Raquel Martinez, Almeida Gomes, Nathalia Lisboa Rosa, Ferrari, Maria Tereza Martins, Elias, Felipe Martins, Rodrigues, Andresa De Santi, Nishi, Mirian Yumie, Silva, Juliana M, Costa, Elaine Maria Frade, Domenice, Sorahia, Mendonca, Berenice Bilharinho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207815/
http://dx.doi.org/10.1210/jendso/bvaa046.1717
_version_ 1783530693644517376
author Batista, Rafael Loch
Ramos, Raquel Martinez
Almeida Gomes, Nathalia Lisboa Rosa
Ferrari, Maria Tereza Martins
Elias, Felipe Martins
Rodrigues, Andresa De Santi
Nishi, Mirian Yumie
Silva, Juliana M
Costa, Elaine Maria Frade
Domenice, Sorahia
Mendonca, Berenice Bilharinho
author_facet Batista, Rafael Loch
Ramos, Raquel Martinez
Almeida Gomes, Nathalia Lisboa Rosa
Ferrari, Maria Tereza Martins
Elias, Felipe Martins
Rodrigues, Andresa De Santi
Nishi, Mirian Yumie
Silva, Juliana M
Costa, Elaine Maria Frade
Domenice, Sorahia
Mendonca, Berenice Bilharinho
author_sort Batista, Rafael Loch
collection PubMed
description Introduction: Androgen Insensitivity Syndrome (AIS) is the most common cause of Differences of Sexual Development (DSD) in 46, XY individuals. It is a X-linked genetic disease caused by allelic variants in the Androgen Receptor Gene (Xq11-12), leading to 3 different phenotypes: Complete (CAIS), Partial (PAIS) or Mild (MAIS). Methods: Patients with clinical suspicion of AIS (familial history, atypical genitalia, primary amenorrhea and/or inguinal hernia) performed hormonal serum measurements (LH, FSH, estradiol, testosterone) and molecular sequencing of the ARgene, including all exonic regions (8 exons) and the 5’UTR region. Psychosexual variables (gender identity, gender role and sexual orientation) were evaluated through questionnaires. Gender identity was also evaluated through projective psychological test (HTP test). A histopathological study and immunostainining of CD240 and OCT3/4 were carried out for all individuals submitted to gonadectomy.Results: This cohort is made up of 64 individuals: CAIS (n=26) and PAIS (n=38), from 46 different families (24 PAIS; 22 CAIS). Inguinal hernia was the first clinical presentation in 35% of CAIS. Among the PAIS, 20 (52%) were assigned as female at birth, while 18 (48%) as male. Among In the group of PAIS, external genitalia virilization (Sinnecker score) influenced sex assignment (p<0.01). Final height and weight were similar between PAIS and CAIS. Furthermore, gender identity at adulthood, gender role at childhood and sexual orientation were in agreement with sex assignment in virtually all cases of both PAIS and CAIS. No gender change was observed. Molecular diagnosis was obtained in 96% of CAIS and in 87% of PAIS. There were 10 novel AR allelic variants (4 in CAIS - 2 small deletions, 1 missenseand 1 at splicing site and PAIS - 5 missenseand 2 synonymous variants (both causing a new exonic splicing site leading to a short AR protein). LH ranged from 9 to 48 UI/L (mean 19), testosterone from 190 to 1500 ng/dL (mean 438), without phenotype differences. Seminoma was identified in 2 out 24 (8%) individuals with CAIS (at 19 and 20 years of age). This rate was higher taking into account only those who underwent gonadectomy after puberty (16 years old or later: 2 out 17 (12%). Among PAIS there were 2 cases of NICG (at 3 and 19 years of age) and none of seminoma. Conclusion: Hormonal levels did not enable us to differ PAIS and CAIS. Inguinal hernia is a common clinical presentation of AIS. External genitalia appearance in PAIS influenced sex assignment. The psychosexual development in AIS usually complies with sex assignment. No gender change was observed. There is a risk of seminoma in CAIS, especially after puberty, which is not low enough to be ignored.
format Online
Article
Text
id pubmed-7207815
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72078152020-05-13 SUN-078 Clinical, Hormonal, Psychosexual Aspects, Gonadal Tumors and Genetic Background of an Androgen Insensitivity Syndrome Cohort Batista, Rafael Loch Ramos, Raquel Martinez Almeida Gomes, Nathalia Lisboa Rosa Ferrari, Maria Tereza Martins Elias, Felipe Martins Rodrigues, Andresa De Santi Nishi, Mirian Yumie Silva, Juliana M Costa, Elaine Maria Frade Domenice, Sorahia Mendonca, Berenice Bilharinho J Endocr Soc Pediatric Endocrinology Introduction: Androgen Insensitivity Syndrome (AIS) is the most common cause of Differences of Sexual Development (DSD) in 46, XY individuals. It is a X-linked genetic disease caused by allelic variants in the Androgen Receptor Gene (Xq11-12), leading to 3 different phenotypes: Complete (CAIS), Partial (PAIS) or Mild (MAIS). Methods: Patients with clinical suspicion of AIS (familial history, atypical genitalia, primary amenorrhea and/or inguinal hernia) performed hormonal serum measurements (LH, FSH, estradiol, testosterone) and molecular sequencing of the ARgene, including all exonic regions (8 exons) and the 5’UTR region. Psychosexual variables (gender identity, gender role and sexual orientation) were evaluated through questionnaires. Gender identity was also evaluated through projective psychological test (HTP test). A histopathological study and immunostainining of CD240 and OCT3/4 were carried out for all individuals submitted to gonadectomy.Results: This cohort is made up of 64 individuals: CAIS (n=26) and PAIS (n=38), from 46 different families (24 PAIS; 22 CAIS). Inguinal hernia was the first clinical presentation in 35% of CAIS. Among the PAIS, 20 (52%) were assigned as female at birth, while 18 (48%) as male. Among In the group of PAIS, external genitalia virilization (Sinnecker score) influenced sex assignment (p<0.01). Final height and weight were similar between PAIS and CAIS. Furthermore, gender identity at adulthood, gender role at childhood and sexual orientation were in agreement with sex assignment in virtually all cases of both PAIS and CAIS. No gender change was observed. Molecular diagnosis was obtained in 96% of CAIS and in 87% of PAIS. There were 10 novel AR allelic variants (4 in CAIS - 2 small deletions, 1 missenseand 1 at splicing site and PAIS - 5 missenseand 2 synonymous variants (both causing a new exonic splicing site leading to a short AR protein). LH ranged from 9 to 48 UI/L (mean 19), testosterone from 190 to 1500 ng/dL (mean 438), without phenotype differences. Seminoma was identified in 2 out 24 (8%) individuals with CAIS (at 19 and 20 years of age). This rate was higher taking into account only those who underwent gonadectomy after puberty (16 years old or later: 2 out 17 (12%). Among PAIS there were 2 cases of NICG (at 3 and 19 years of age) and none of seminoma. Conclusion: Hormonal levels did not enable us to differ PAIS and CAIS. Inguinal hernia is a common clinical presentation of AIS. External genitalia appearance in PAIS influenced sex assignment. The psychosexual development in AIS usually complies with sex assignment. No gender change was observed. There is a risk of seminoma in CAIS, especially after puberty, which is not low enough to be ignored. Oxford University Press 2020-05-08 /pmc/articles/PMC7207815/ http://dx.doi.org/10.1210/jendso/bvaa046.1717 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Pediatric Endocrinology
Batista, Rafael Loch
Ramos, Raquel Martinez
Almeida Gomes, Nathalia Lisboa Rosa
Ferrari, Maria Tereza Martins
Elias, Felipe Martins
Rodrigues, Andresa De Santi
Nishi, Mirian Yumie
Silva, Juliana M
Costa, Elaine Maria Frade
Domenice, Sorahia
Mendonca, Berenice Bilharinho
SUN-078 Clinical, Hormonal, Psychosexual Aspects, Gonadal Tumors and Genetic Background of an Androgen Insensitivity Syndrome Cohort
title SUN-078 Clinical, Hormonal, Psychosexual Aspects, Gonadal Tumors and Genetic Background of an Androgen Insensitivity Syndrome Cohort
title_full SUN-078 Clinical, Hormonal, Psychosexual Aspects, Gonadal Tumors and Genetic Background of an Androgen Insensitivity Syndrome Cohort
title_fullStr SUN-078 Clinical, Hormonal, Psychosexual Aspects, Gonadal Tumors and Genetic Background of an Androgen Insensitivity Syndrome Cohort
title_full_unstemmed SUN-078 Clinical, Hormonal, Psychosexual Aspects, Gonadal Tumors and Genetic Background of an Androgen Insensitivity Syndrome Cohort
title_short SUN-078 Clinical, Hormonal, Psychosexual Aspects, Gonadal Tumors and Genetic Background of an Androgen Insensitivity Syndrome Cohort
title_sort sun-078 clinical, hormonal, psychosexual aspects, gonadal tumors and genetic background of an androgen insensitivity syndrome cohort
topic Pediatric Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207815/
http://dx.doi.org/10.1210/jendso/bvaa046.1717
work_keys_str_mv AT batistarafaelloch sun078clinicalhormonalpsychosexualaspectsgonadaltumorsandgeneticbackgroundofanandrogeninsensitivitysyndromecohort
AT ramosraquelmartinez sun078clinicalhormonalpsychosexualaspectsgonadaltumorsandgeneticbackgroundofanandrogeninsensitivitysyndromecohort
AT almeidagomesnathalialisboarosa sun078clinicalhormonalpsychosexualaspectsgonadaltumorsandgeneticbackgroundofanandrogeninsensitivitysyndromecohort
AT ferrarimariaterezamartins sun078clinicalhormonalpsychosexualaspectsgonadaltumorsandgeneticbackgroundofanandrogeninsensitivitysyndromecohort
AT eliasfelipemartins sun078clinicalhormonalpsychosexualaspectsgonadaltumorsandgeneticbackgroundofanandrogeninsensitivitysyndromecohort
AT rodriguesandresadesanti sun078clinicalhormonalpsychosexualaspectsgonadaltumorsandgeneticbackgroundofanandrogeninsensitivitysyndromecohort
AT nishimirianyumie sun078clinicalhormonalpsychosexualaspectsgonadaltumorsandgeneticbackgroundofanandrogeninsensitivitysyndromecohort
AT silvajulianam sun078clinicalhormonalpsychosexualaspectsgonadaltumorsandgeneticbackgroundofanandrogeninsensitivitysyndromecohort
AT costaelainemariafrade sun078clinicalhormonalpsychosexualaspectsgonadaltumorsandgeneticbackgroundofanandrogeninsensitivitysyndromecohort
AT domenicesorahia sun078clinicalhormonalpsychosexualaspectsgonadaltumorsandgeneticbackgroundofanandrogeninsensitivitysyndromecohort
AT mendoncaberenicebilharinho sun078clinicalhormonalpsychosexualaspectsgonadaltumorsandgeneticbackgroundofanandrogeninsensitivitysyndromecohort